Requirements for human chorionic gonadotropin and recombinant human luteinizing hormone for follicular development and maturation

Journal of Assisted Reproduction and Genetics

Volumn 16, Issue 8, 1999, Pages 425-430

  Andersen, Claus Yding ^a   Ziebe, SØren ^a   Guoliang, Xia ^a   Byskov, Anne Grete ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Blastocysts; Follicle stimulating hormone; Human chorionic gonadotropin; Oocyte maturation; Ovarian stimulation; Preembryos; Recombinant luteinizing hormone

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; LUTEINIZING HORMONE; RECOMBINANT LUTEINIZING HORMONE; UNCLASSIFIED DRUG; UROFOLLITROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLASTOCYST; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; OVARY FOLLICLE MATURATION; OVULATION INDUCTION; PRIORITY JOURNAL;

ANIMALS; BLASTOCYST; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; LUTEINIZING HORMONE; MICE; MICE, INBRED STRAINS; OOCYTES; OVARIAN FOLLICLE; PREGNANCY; PREGNANCY, ANIMAL; RECOMBINANT PROTEINS;

ANIMALIA; FALLOPIA;

EID: 0032822908     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020569508927     Document Type: Article

References (21)

1. Chappel S, Howles C: Reevaluation of the roles of lutenizing hormone and follicle-stimulating hormone in the ovulatory process. Hum Reprod 1991;6:1206-1212
2. Shoham Z, Jacobs HS, Insler V: Lutenizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertil Steril 1993;59:1153-1161
3. Howles C, MacName MC, Edwards RG: Effect of high tonic levels of luteinizing hormone on outcome of in vitro fertilization. Lancet 1986;2:521-522
4. Conway GS, Honour JW, Jacobs HS: Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features. Clin Endorcrinol 1989;30:459-470
5. Regan L, Owen EJ, Jacobs HS: Hypersecretion of luteinizing hormone, infertility and miscarriage. Lancet 1989;336:1141-1144
6. Westergaard LG, Erb K, Laursen S, Rex S, Rasmussen PE: The effect of human menopausal gonadotropin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotropic women. Hum Reprod 1996;11:1209-1213
7. Agrawal R, Conway GS, Engmann L: Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization. Gynecol Endocrinol 1998;12:9-15
8. Balasch J, Miro F, Burzaco I: The role of luteinizing hormone in human follicle development and oocyte fertility: Evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone. Hum Reprod 1995;10:1678-1683
9. Shoham Z, Balen A, Patel A: Results of ovulation induction using human menopausal gonadotropin or purified follicle- stimulating hormone in hypogonadotropin hypogonadism patients. Fertil Steril 1991;56:1048-1053
10. Shoham Z: Effects of different menotropin preparations for ovulation induction in hypogonadotropic women. In The Role of Luteinizing Hormone in Folliculogenesis and Ovulation Induction, M Fillicori (ed). Bologna, Monduzzi Editore, 1999, pp 105-114
11. Gordon UD: Effects of different menotropin preparations for assisted reproduction in hypogonadotropic hypogonadism. In The Role of Luteinizing Hormone in Folliculogenesis and Ovulation Induction, M Fillicori (ed). Bologna, Monduzzi Editore, 1999, pp 135-144
12. Westergaard LG: Clinical outcome of in-vitro fertilization: hMG versus purified FSH. In The Role of Luteinizing Hormone in Folliculogenesis and Ovulation Induction, M Fillicori (ed). Bologna, Monduzzi Editore, 1999, pp 173-188
13. Ziebe S, Guoliang X, Byskov AG: Impact of gonadotropin dose on pre-embryo recovery and development in superovulated mice. Hum Reprod 1993;8:385-388
14. Mannaerts B, Leeuw R, Geelen J: Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle-stimulating hormone. Endocrinology 1991;129:2623-2630
15. Yding Andersen C, Westergaard LG, Byskov AG, Erb K: Reduced in vitro fertilization of human oocytes correlates with raised circulating FSH levels during ovarian stimulation in normogonadotrophic women downregulated with GnRH-analogues. J Assist Reprod Genet 1997;14:581-588
16. Couzinet B, Lestrat N, Brailly S: Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency. J Clin Endocrinol Metab 1988;66:552-556
17. Flemming R, Lloyd F, Herbert M: Effects of profound suppression on luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Hum Reprod 1998;13:1788-1792
18. Wang XN, Greenwald GS: Human chorionic gonadotropin or human recombinant follicle-stimulating hormone(FSH)-induced ovulation and subsequent fertilization and early embryo development in hypophysectiomized FSH-primed mice. Endocrinology 1993;132:2009-2016
19. Wang XN, Greenwald GS: Hypophysectomy of the cyclic mouse. II. Effects of follicle-stimulating hormone (FSH) and luteinizing hormone on folliculogenesis, FSH and human chrorionc gonadotropin receptors, and steroidogenesis. Biol Reprod 1993;48:595-605
20. Stokman PG, de Leeuw R, van den Wijngaard HA: Human chorionic gonadotropins in commercial menopausal gonadotropin preparations. Fertil Steril 1993;60:175-178
21. Odell WD, Griffin J: Pulsatile secretion of chorionic gonadotropin during the normal menstrual cycle. J Clin Endocrinol Metab 1989;69:528-532